Neuprozyme Therapeutics ApS
Registration details
Company overview
Neuprozyme Therapeutics ApS is a Private limited company (Ltd.) registered in Denmark under 40010106, and its current status with Danish Business Authority — CVR (Central Business Register) is active. The company was incorporated on 19 September 2018 and lists its registered address as Hørsholm, Denmark. 1 shareholder is on record for Neuprozyme Therapeutics ApS, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Danish Business Authority — CVR (Central Business Register) and was last updated on 8 November 2026.
Officers
2
Registry notes and limitations
Two officers are currently on record for Neuprozyme Therapeutics ApS, filed with Danish Business Authority — CVR (Central Business Register). John Pedersen (appointed 2018-09-19) serves as Direktør; Lone Ballegaard Pedersen (appointed 2018-09-19) serves as Bestyrelsesmedlem.
Management authority at Neuprozyme Therapeutics ApS sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Ljp Holding ApS
Denmark
How these relationships were recorded
Neuprozyme Therapeutics ApS sits 1 level below its ultimate parent, Ljp Holding ApS, registered in Denmark. Immediately above Neuprozyme Therapeutics ApS is Ljp Holding ApS, holding 100% as filed in Neuprozyme Therapeutics ApS's own shareholder record with Danish Business Authority — CVR (Central Business Register).
Frequently asked questions
Who owns Neuprozyme Therapeutics ApS?
One shareholder is currently on record for Neuprozyme Therapeutics ApS, filed with Danish Business Authority — CVR (Central Business Register). The largest of these is LJP HOLDING ApS, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Neuprozyme Therapeutics ApS's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Neuprozyme Therapeutics ApS is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Neuprozyme Therapeutics ApS have on record?
1 shareholder is shown on record for Neuprozyme Therapeutics ApS.
What is Neuprozyme Therapeutics ApS's company registration number?
Neuprozyme Therapeutics ApS's registration number is 40010106, filed with Danish Business Authority — CVR (Central Business Register) in Denmark. Its current status on the register is active.
Is Neuprozyme Therapeutics ApS still an active company?
Neuprozyme Therapeutics ApS's status on Danish Business Authority — CVR (Central Business Register) is listed as active.
When was Neuprozyme Therapeutics ApS incorporated?
Neuprozyme Therapeutics ApS was incorporated on 19 September 2018, according to Danish Business Authority — CVR (Central Business Register).
What is Neuprozyme Therapeutics ApS's registered address?
The registered address on file for Neuprozyme Therapeutics ApS is Hørsholm, Denmark.
What legal structure is Neuprozyme Therapeutics ApS registered as?
Neuprozyme Therapeutics ApS is registered as a Private limited company (Ltd.) in Denmark.
Who are the officers/directors of Neuprozyme Therapeutics ApS?
Two officers are currently on record for Neuprozyme Therapeutics ApS, filed with Danish Business Authority — CVR (Central Business Register). John Pedersen (appointed 2018-09-19) serves as Direktør; Lone Ballegaard Pedersen (appointed 2018-09-19) serves as Bestyrelsesmedlem. Management authority at Neuprozyme Therapeutics ApS sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Neuprozyme Therapeutics ApS have a parent company or subsidiaries?
Neuprozyme Therapeutics ApS sits 1 level below its ultimate parent, Ljp Holding ApS, registered in Denmark.
Can Zavia monitor changes to Neuprozyme Therapeutics ApS's ownership over time?
This profile reflects a point-in-time snapshot from Danish Business Authority — CVR (Central Business Register). Zavia's monitoring API can track changes to Neuprozyme Therapeutics ApS's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Neuprozyme Therapeutics ApS's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Denmark, so records like Neuprozyme Therapeutics ApS's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Danish Business Authority — CVR (Central Business Register) and was last synced on 8 November 2026.